Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-03 Sale |
2025-02-04 8:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks |
2,173 | $12.7 | $27,597 | 135,555 (Direct) |
View |
| 2024-11-30 Purchase |
2024-12-03 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks |
1,093 | $7.106 | $7,767 | 137,728 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-03 4:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer |
3,725 | $10.01 | $37,295 | 136,635 (Direct) |
View |
| 2024-05-17 Sale |
2024-05-20 5:12 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer |
7,640 | $8.9767 | $68,582 | 140,360 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks |
197,000 | $0 | 332,555 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 5:12 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer |
60,000 | $0 | 140,360 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:34 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd Chief Commercial Officer |
204,000 | $0 | 264,000 (Direct) |
View |
| 2023-09-27 Option Award |
2023-10-03 9:45 pm |
N/A 2033-09-27 |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd Chief Commercial Officer |
300,000 | $0 | 300,000 (Direct) |
View |